Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
JACC. Cardiovascular Imaging|October 18, 2011
Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imagingEsad Vucic, Stephen D Dickson, Claudia Calcagno, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Discovery and initial SAR of 2-amino-5-carboxamidothiazoles as inhibitors of the Src-family kinase p56(Lck)John Wityak, Jagabandhu Das, Robert V Moquin, et al.
Bioorganic & Medicinal Chemistry Letters|October 10, 2002
Synthesis and SAR of novel imidazoquinoxaline-based Lck inhibitors: improvement of cell potencyPing Chen, Edwin J Iwanowicz, Derek Norris, et al.
Science Advances|February 22, 2023
Ring-stacked capsids of white spot syndrome virus and structural transitions with genome ejectionMeiling Sun, Mingdong Liu, Hong Shan, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2008
Benzothiazole based inhibitors of p38alpha MAP kinaseChunjian Liu, James Lin, Sidney Pitt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2016
Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancerFortunato Ferrara, Daniela I Staquicini, Wouter H P Driessen, et al.
Plos One|May 5, 2016
Urine Exosomes for Non-Invasive Assessment of Gene Expression and Mutations of Prostate CancerPiruz Motamedinia, Anna N Scott, Kendall L Bate, et al.
JACC. Cardiovascular Imaging|August 18, 2012
Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatinEsad Vucic, Claudia Calcagno, Stephen D Dickson, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2006
Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitorsJagabandhu Das, Chunjian Liu, Robert V Moquin, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Molecular design and structure--activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664Jagabandhu Das, S David Kimball, Steven E Hall, et al.
Pageof 25